Physician

Mouhamad Bazzi, MD

According to 2025 Medicare claims, Mouhamad Bazzi, MD (NPI: 1265619878) practices hematology/oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Frederick, MD. This provider's primary affiliated billing organization is PROGRESSIVE ONCOLOGY AND HEMATOLOGY CENTER LLC (NPI: 1578959615; TIN: 473613140) and primary practice location at 21702-3361.

Bazzi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 397 traditional Medicare patients, billed 216,904 HCPCS/CPT codes, and received $4,931,209 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,308 prescription claims across 177 beneficiaries totaling $4,412,713 in drug costs, led by Xtandi (Enzalutamide). DME data shows 33 claims. Open Payments data shows 41 records totaling $893. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,254,944 to $4,931,209. Similarly, Part D prescription costs have moved sharply higher in recent years, from $444,566 to $4,412,713. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,220 and ending at $2,062.